Find your next paid study

Emory UniversityNCT07150546

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

Phase I/II Trial of Systemic Targeted Radioligand Therapy (TRT) With Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR Positive (SSTR+) Gastrointestinal (GI) Neuroendocrine Tumors (NET) and Pheochromocytoma/Paragangliomas Previously Treated With Systemic Radioligand Therapy

Background: Gastrointestinal neuroendocrine tumors (GI NET) are a type of cancer that affects the stomach and intestines; pheochromocytoma/paragangliomas (PPG…

Somatostatin Receptor PositiveGastrointestinal Neuroendocrine TumorsPheochromocytoma+1 more

National Cancer Institute (NCI)NCT06427798

~$150 – $2,700

Actual pay is set by the research site.

Phase 1

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Background: Neuroendocrine neoplasms (NENs) are rare cancers in the gastrointestinal tract, pancreas, lungs, adrenal glands, and other areas of the body. Many…

Neuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more

National Cancer Institute (NCI)NCT06041516

~$150 – $2,700

Actual pay is set by the research site.

Malignant Brain NeoplasmMalignant Solid NeoplasmMultiple Sclerosis+2 more

Enhancing Brain and Mental Health Through Respiratory Training: Clinical Applications in Cancer and Neurodegenerative Disease Care for Patients and Caregivers (Breathing Study)

This clinical trial studies the effect of respiratory training for enhancing brain and mental health among patients with multiple sclerosis (MS) and cancer (al…

Gastroenteropancreatic Neuroendocrine Tumor

Actual pay is set by the research site.

Mayo ClinicNCT06788886

Treatment Patterns and Outcomes in GEP NET: A Retrospective Observational Cohort Study (PRIME Initiative)

This study aims to characterize current treatment patterns and clinical outcomes among newly diagnosed GEP-NET patients in the United States using open-source …

Novartis PharmaceuticalsNCT07635316

~$10 – $1,050

Actual pay is set by the research site.

CancerCancer SurvivorsGastrointestinal Cancers+2 more

Addressing Social Determinants of Health (SDOH) Among Metro Detroit Cancer Survivors: A Pilot Feasibility Study (The Resource Ready Study)

The goal of this screening study is to determine the feasibility of completing a social needs screening tool in participants who have a past or current cancer …

Barbara Ann Karmanos Cancer InstituteNCT06908629

~$10 – $1,125

Actual pay is set by the research site.

Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Neuroendocrine Tumor (NET)

Feasibility, Tolerance, and Fat Metabolism Pilot Study of a Structured Lipid Medical Food in Patients With Pancreatic Cancer

Patients with pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumor (NET)) commonly experience fat malabsorption due t…

Children's Hospital of PhiladelphiaNCT07554560

Actual pay is set by the research site.

Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine

The specific aim is of this study is to gain a better understanding of the patient characteristics, treatment responses, survival outcomes, and adverse events …

Neuroendocrine TumorsGastroenteropancreatic Neuroendocrine Tumor

Methodist Health SystemNCT04090034

Actual pay is set by the research site.

Pancreatic NeoplasmPancreatic Neuroendocrine Tumor

Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation of Pancreatic Neoplasms - A Safety and Feasibility Trial

This clinical trial tests the safety and feasibility of endoscopic ultrasound-guided pulsed electric field ablation for the treatment of pancreatic neoplasms. …

Ohio State University Comprehensive Cancer CenterNCT07619417

Actual pay is set by the research site.

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Background: \- Laboratory investigators who are studying common childhood cancers are interested in developing a tissue repository to collect and store blood,…

SarcomaEndocrine TumorsNeuroblastoma+2 more

National Cancer Institute (NCI)NCT01109394

~$10 – $675

Actual pay is set by the research site.

Phase 1

Biodistribution of 68Ga Pentixafor in Patients With Small Cell Lung Carcinoma (SCLC)

This is a first-in-human clinical trial evaluating the safety of an alpha-radiation treatment (Lead-212 labelled Pentixather) in patients who have been diagnos…

Carcinoid Tumor LungNeuroendocrine Tumor of the LungCarcinoma, Small-Cell Lung

Metastatic Renal Cell CarcinomaClear-cell Metastatic Renal Cell CarcinomaNeuroendocrine Tumors+1 more

~$150 – $4,500

Actual pay is set by the research site.

Yusuf MendaNCT05557708

Phase 2

GU-187: Phase II Trial of Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

This is a multi-site, three-cohort phase II trial of cabozantinib for IMDC all-risk frontline metastatic renal cell carcinoma (mRCC) patients OR any line mRCC …